https://medicaldialogues.in/news/industry/pharma/merck-vs-mylan-pharma-us-court-of-appeals-for-the-federal-circuit-rules-in-favor-of-merck-in-sitagliptin-dihydrogen-phosphate-patent-lawsuit-100004